A radioimmunoprecipitation assay for antibodies to botulinum A

Neurology

Volumn 50, Issue 5, 1998, Pages 1463-1466

  Palace, J ^a   Nairne, A ^b   Hyman, N ^b   Doherty, T V ^c   Vincent, Angela ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c Northview Pacific Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; BIOASSAY; BLOOD SAMPLING; DOSE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; RADIOIMMUNOPRECIPITATION; RECEPTOR AFFINITY; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; SENSITIVITY AND SPECIFICITY;

ANTIBODIES; BIOLOGICAL ASSAY; BOTULINUM TOXIN TYPE A; CASE-CONTROL STUDIES; HUMANS; RADIOIMMUNOPRECIPITATION ASSAY; SENSITIVITY AND SPECIFICITY;

EID: 0031596997     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.5.1463     Document Type: Article

References (10)

1. Jankovic J, Hallett M, eds. Therapy with botulinum toxin. New York: Marcel Dekker, 1994.
2. Jankovic J, Schwartz K. Response and immunoresistance to botulinum toxin injections. Neurology 1995;45:1743-1746.
3. Sheean GL, Lees AJ. Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A. J Neurol Neurosurg Psychiatry 1995;59:601-607.
4. Borodic G, Johnson E, Goodnough M, Schantz E. Botulinum toxin therapy, immunologic resistance, and problems with available materials. Neurology 1996;46:26-29.
5. Zuber M, Sebald M, Bathien N, de Recondo J, Rondot P. Botulinum antibodies in dystonic patients treated with type A botulinum toxin. Neurology 1993;43:1715-1718.
6. Hatheway CL, Dang C. Immunogenicity of the neurotoxins of Clostridium botulinum. In: Jankovic J, Hallett M, eds. Therapy with botulinum toxin. New York: Marcel Dekker, 1994: 93-108.
7. Tsui JK, Wong NLM, Wong E, Calne DB. Production of circulating antibodies to botulinum-A toxin in patients receiving repeated injections for dystonia. Ann Neurol 1988;24:181.
8. Siatkowksi RM, Tyutyunikov A, Biglan AW, et al. Serum antibody production to botulinum A toxin. Ophthalmology 1993; 100:1861-1866.
9. 125I-Bot. J Neurol Neurosurg Psychiatry 1996;61:224. Abstract.
10. Shone CC, Tranter HS, Alexander FCG. Purification and radiolabeling of Clostridium botulinum type F neurotoxin. Methods Neurosci 1992:8:165-179.